Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Alyssa Schlenz to Child

This is a "connection" page, showing publications Alyssa Schlenz has written about Child.

 
Connection Strength
  
 
 
0.444
  
  1. Schlenz AM, Thomas SJ, Gloston G, Lebensburger J, Maxwell SL, Kanter J. Sleep quality and pain in adolescents and young adults with sickle cell disease. J Clin Sleep Med. 2022 12 01; 18(12):2845-2853.
    View in: PubMed
    Score: 0.056
  2. Schlenz AM, Phillips SM, Mueller M, Melvin CL, Adams RJ, Kanter J. Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia. J Pediatr Hematol Oncol Nurs. 2022 Jul-Aug; 39(4):209-220.
    View in: PubMed
    Score: 0.054
  3. Schlenz AM, Phillips S, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
    View in: PubMed
    Score: 0.046
  4. Schlenz AM, Schatz J, Roberts CW. Examining Biopsychosocial Factors in Relation to Multiple Pain Features in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2016 Sep; 41(8):930-40.
    View in: PubMed
    Score: 0.035
  5. Schlenz AM, Boan AD, Lackland DT, Adams RJ, Kanter J. Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012. Public Health Rep. 2016 Jan-Feb; 131(1):108-16.
    View in: PubMed
    Score: 0.035
  6. Schlenz AM, Carpenter LA, Bradley C, Charles J, Boan A. Age Differences in Emergency Department Visits and Inpatient Hospitalizations in Preadolescent and Adolescent Youth with Autism Spectrum Disorders. J Autism Dev Disord. 2015 Aug; 45(8):2382-91.
    View in: PubMed
    Score: 0.034
  7. Schlenz AM, McClellan CB, Mark TR, McKelvy AD, Puffer E, Roberts CW, Sweitzer SM, Schatz JC. Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1. J Pain. 2012 Jul; 13(7):656-65.
    View in: PubMed
    Score: 0.027
  8. Schlenz AM, Schatz J, McClellan CB, Roberts CW. Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease. J Pediatr Psychol. 2012 Aug; 37(7):798-807.
    View in: PubMed
    Score: 0.027
  9. Schlenz AM, Schatz J, McClellan CB, Sweitzer SM, Roberts CW. Information-seeking coping behaviors during painful procedures in African-American children with sickle cell disease. Pain Manag Nurs. 2013 Sep; 14(3):e54-8.
    View in: PubMed
    Score: 0.026
  10. Fraley CE, Neiman JS, Feddersen CR, James C, Jones TG, Mikkelsen M, Nuss R, Schlenz AM, Winters AC, Green AL, Compas BE. Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease. Pediatr Blood Cancer. 2023 06; 70(6):e30299.
    View in: PubMed
    Score: 0.014
  11. Phillips S, Schlenz AM, D'Alton S, Johnson M, Kanter J. Patient and Family Opioid Decision-Making for Pain Management in Sickle Cell Disease: A Qualitative Study. J Pain. 2023 07; 24(7):1240-1250.
    View in: PubMed
    Score: 0.014
  12. Noisette ML, Phillips S, Schlenz AM, Mueller M, Kanter J. Changes in Care Delivery for Children With Sickle Cell Anemia During the COVID-19 Pandemic. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1231-e1234.
    View in: PubMed
    Score: 0.013
  13. Kanter J, Phillips S, Schlenz AM, Mueller M, Dooley M, Sirline L, Nickel R, Brown RC, Hilliard L, Melvin CL, Adams RJ. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
    View in: PubMed
    Score: 0.013
  14. Phillips S, Schlenz AM, Mueller M, Melvin C, Adams RJ, Kanter J. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569.
    View in: PubMed
    Score: 0.012
  15. Maxwell SL, Schlenz AM, Kanter J. Health-related Quality of Life in Children With Sickle Cell Disease Undergoing Chronic Red Cell Transfusion Therapy. J Pediatr Hematol Oncol. 2019 05; 41(4):307-312.
    View in: PubMed
    Score: 0.011
  16. Schatz J, Schlenz AM, Smith KE, Roberts CW. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study. Dev Med Child Neurol. 2018 05; 60(5):520-526.
    View in: PubMed
    Score: 0.010
  17. Schatz J, Schlenz AM, McClellan CB, Puffer ES, Hardy S, Pfeiffer M, Roberts CW. Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones. Clin J Pain. 2015 Jun; 31(6):536-47.
    View in: PubMed
    Score: 0.008
  18. Smith TP, Schlenz AM, Schatz JC, Maitra R, Sweitzer SM. Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation. Blood Cells Mol Dis. 2015 Feb; 54(2):155-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)